Abstract
Many countries are now considering value-based pricing (VBP) to curb the rising cost of pharmaceuticals and health care spending, while maximizing the value of the drug to the population. One of the most well-used tools to implement VBP in healthcare is using cost-effectiveness analysis (CEA) directly to drive the pricing strategy that sets the right incentives for healthcare systems, or indirectly as part of their multi-criteria decision analysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
